Entrada Therapeutics Inc (TRDA) — Defensive Interval Ratio
Entrada Therapeutics Inc (TRDA) has a Defensive Interval Ratio of 2127 days as of June 2026. Defensive assets of $124.54 Million (cash $-, short-term investments $123.72 Million, receivables $816.00K) cover 2127 days of daily cash needs of $58.55K/day. See Entrada Therapeutics Inc (TRDA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Entrada Therapeutics Inc Defensive Interval Ratio (2021–2025)
This chart shows how Entrada Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 2127 days, meaning defensive assets of $124.54 Million can fund 2127 days of operations without new revenue. Read how much debt does Entrada Therapeutics Inc carry for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Entrada Therapeutics Inc (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Entrada Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Entrada Therapeutics Inc asset portfolio.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3103 days | $207.88 Million | $66.99K/day | $- | $205.30 Million | ▲ +122 days |
| 2024 | 2981 days | $322.47 Million | $108.17K/day | $- | $318.79 Million | ▲ +2314 days |
| 2023 | 667 days | $290.25 Million | $435.06K/day | $- | $284.37 Million | ▼ -1718 days |
| 2022 | 2385 days | $143.56 Million | $60.20K/day | $- | $143.56 Million | ▲ +2337 days |
| 2021 | 47 days | $872.00K | $18.41K/day | $- | $0.00 | — |